We found a significantly decreased expression of mTOR and phospho-mTOR (p-mTOR) proteins after VP treatment either alone or in combination with SF for both HCC cell lines (Supplementary Fig. 5A-B). The gene discussed is MTOR; the disease is hepatocellular carcinoma.